Sector pending / Life InsuranceUpdated 2026-05-10 22:07 UTC

FRA/PCR stock hub

FRA/PCR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/PCRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30.8B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/PCR

In the news

Latest news · FRA/PCR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13

P25 n/aP50 n/aP75 n/a

Trailing P/E19.3

P25 n/aP50 n/aP75 n/a

ROE9.9

P25 n/aP50 n/aP75 n/a

ROIC7.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/PCR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

CAD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	DE
Employees	30,000
Employees Change	-484%
Employees Change Percent	-1.59
Enterprise value	EUR 54.9B
Exchange	Frankfurt Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Life Insurance
Last refreshed	2026-05-10
Market cap	EUR 30.8B
Price	EUR 48.95
Price currency	EUR
Rev Per Employee	802,677.18x
Sic	6311
Symbol	fra/PCR
Website	https://www.powercorporation.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.18%
EV Earnings	34.38x
EV/EBIT	13.61x
EV/EBITDA	11.78x
EV/FCF	21.28x
EV/Sales	2.28x
FCF yield	8.37%
Forward P/E	12.99x
P/B ratio	1.1x
P/E ratio	19.29x
P/S ratio	1.28x
PE Ratio10 Y	11.19x
PE Ratio3 Y	12.38x
PE Ratio5 Y	11.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.59%
EBITDA Margin	17.92%
FCF margin	10.72%
Gross margin	51.73%
Gross Profit	EUR 12.5B
Net Income	EUR 1.6B
Net Income Growth	-6.01%
Net Income Growth Q	-55.18%
Net Income Growth3 Y	5.43%
Net Income Growth5 Y	5.22%
Pretax Margin	13.61%
Profit Margin	6.78%
Profit Per Employee	EUR 53,255
ROA	0.42
Roa5y	0.45
ROCE	0.66
ROE	9.88
Roe5y	9.95
ROIC	7.11
Roic5y	7.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.8%
Cagr15y	11.85%
Cagr1y	56.47%
Cagr3y	33.4%
Cagr5y	20.91%
Div CAGR10	6.13%
Div CAGR3	2.66%
Div CAGR5	5.98%
EPS Growth	-6
EPS Growth Q	-56.93
EPS Growth3 Y	6.89
EPS Growth5 Y	5.04
FCF Growth	-17.18%
FCF Growth Q	-56.57%
FCF Growth3 Y	6.39%
FCF Growth5 Y	-15.62%
OCF Growth	-18.86%
OCF Growth Q	-58.36%
OCF Growth10 Y	-1.77%
OCF Growth3 Y	3.96%
OCF Growth5 Y	-13.9%
Revenue Growth	6.54x
Revenue Growth Q	4.14x
Revenue Growth3 Y	7.07x
Revenue Growth5 Y	-9.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.04
Assets	EUR 575B
Cash	EUR 124.4B
Debt	EUR 18.9B
Debt EBITDA	EUR 4.31
Debt Equity	EUR 0.67
Debt FCF	EUR 7.31
Equity	EUR 28B
Interest Coverage	7.51
Liabilities	EUR 547.1B
Net Cash	EUR -10.5B
Net Cash By Market Cap	EUR -34
Net Debt EBITDA	EUR 2.43
Net Debt Equity	EUR 0.37
Net Debt FCF	EUR 4.06
Tangible Book Value	EUR 863.4M
Tangible Book Value Per Share	EUR 1.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	16.32
Net Working Capital	EUR 149.7B
Quick ratio	13
Working Capital	EUR 153.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.86%
Dividend Growth	1.82%
Dividend Growth Years	4%
Dividend per share	EUR 1.56
Dividend Years	22
Dividend Yield	3.18%
Ex Div Date	2026-03-31
Last Dividend	EUR 0.42
Payout Frequency	Quarterly
Payout Ratio	60.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	333.38%
1Y total return	56.42%
200-day SMA	40.47
3Y total return	137.45%
50-day SMA	43.27
50-day SMA vs 200-day SMA	50over200
5Y total return	158.36%
All Time High	48.95
All Time High Change	0%
All Time High Date	2026-05-08
All Time Low	9.08
All Time Low Change	439.1%
All Time Low Date	2009-03-10
ATR	0.58
Ch YTD	8.3
High	48.95
High52	48.95
High52 Date	2026-05-08
High52ch	0%
Low	48.95
Low52	31
Low52 Date	2025-05-15
Low52ch	57.9%
Ma50ch	13.13%
Price vs 200-day SMA	20.96%
RSI	75.85
RSI Monthly	77.78
RSI Weekly	72.51
Sharpe ratio	2.06x
Sortino ratio	3.41
Total Return	4.04%
Tr YTD	10.34
Tr15y	436.45%
Tr1m	15.53%
Tr1w	2.97%
Tr3m	21.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 3.8B
Operating margin	15.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	580,976,000%
Net Borrowing	-364,107,892.2
Shares Insiders	0.57%
Shares Institutions	31.91%
Shares Qo Q	-0.79%
Shares Yo Y	-0.86%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2.6B
Average Volume	5.3x
Bv Per Share	22.55
CAPEX	EUR -388.2M
Ch10y	151.1
Ch15y	150.9
Ch1m	15.53
Ch1w	2.97
Ch1y	50.15
Ch3m	19.98
Ch3y	104
Ch5y	99.31
Ch6m	20.57
Change	1.32%
Change From Open	0
Close	48.31
Days Gap	1.32
Earnings Date	2026-05-12
EBIT	EUR 3.8B
EBITDA	EUR 4.3B
EPS	EUR 2.45
F Score	5
FCF	EUR 2.6B
FCF EV Yield	4.7x
Financing CF	-2,280,318,789
Fiscal Year End	December
Founded	1,925
Goodwill	9,094,013,300.2
Graham Number	50.37233
Graham Upside	2.91
Income Tax	EUR 545.4M
Investing CF	-216,167,513
Is Primary Listing	0
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Lynch Fair Value	EUR 13.25
Lynch Upside	-72.93
Ma150	42.19
Ma150ch	16.03%
Ma20	45.83
Ma20ch	6.82%
Net CF	386,368,370
Next Earnings Date	2026-05-12
Open	48.95
P FCF Ratio	11.94
P OCF Ratio	10.38
Payment Date	2026-05-01
Ppne	4,059,151,697.5
Price Date	2026-05-08
Price EBITDA	EUR 7.14
Ptbv Ratio	35.7
Relative Volume	5.09x
Revenue	24,080,315,490x
Tax By Revenue	2.26x
Tax Rate	16.64%
Tr6m	22.84%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/PCR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.2%

$1.56 annual per share

Payout ratio

+60.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.0%

4 consecutive years of growth

Total shareholder yield

+4.0%

Next ex-dividend date: 2026-03-31

Performance

FRA/PCR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/PCR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.9%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.9%

Negative means the company is buying back shares.

Technical

FRA/PCR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

75.9

Above 70: short-term overbought

Price vs 200-day MA

+21.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/PCR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/PCR stock rating?

fra/PCR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/PCR analysis?

The full report lives at /stocks/fra/PCR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/PCR?

The latest report frames fra/PCR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/PCR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.